Inogen Inc(INGN-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low6.54
Day High6.84
Open:6.54
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Tipranks
Inogen Shareholders Approve Expanded Equity Incentive Plan
Tipranks
Inogen Earnings Call: International Strength Amid U.S. Strain
MarketBeat
Inogen Q1 Earnings Call Highlights
MarketBeat.com
Motley Fool
Inogen (INGN) Q1 2026 Earnings Transcript
Tipranks
Analysts Offer Insights on Healthcare Companies: Evotec AG (EVO), Legend Biotech (LEGN) and Inogen (INGN)
Tipranks
Inogen Adds Director Amid Cooperation Agreement With Shareholder
Tipranks
Inogen Earnings Call Shows Turnaround Amid Mixed Headwinds
Tipranks
Inogen Posts 2025 Results and Launches Share Buyback
Tipranks
Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Inogen (INGN)
Tipranks
B. Riley Securities Reaffirms Their Buy Rating on Inogen (INGN)
Tipranks
Analysts Offer Insights on Healthcare Companies: Inogen (INGN), Exelixis (EXEL) and Ultragenyx Pharmaceutical (RARE)
Zacks Investment Research
How to Find the Best Value Stock Screens for 2026
How to Find the Best Value Stock Screens for 2026
Zacks Investment Research
3 MedTech Innovators Shaping Healthcare in 2026: AVAH, INGN & CCLD
3 MedTech Innovators Shaping Healthcare in 2026: AVAH, INGN & CCLD
Tipranks
Inogen Inc’s Earnings Call: Growth Amid Challenges
Tipranks
Analysts Are Bullish on These Healthcare Stocks: Natera (NTRA), Inogen (INGN)
Business Wire
Inogen Announces Third Quarter 2025 Financial Results
Business Wire
Inogen to Report Third Quarter 2025 Financial Results on November 5, 2025
Business Wire
Inogen Announces the Appointment of Naga Rameswamy as Chief Technology Officer
Zacks Investment Research
Masimo Completes Divestment of Consumer Audio Business to HARMAN
Masimo Completes Divestment of Consumer Audio Business to HARMAN

Profile

Inogen Inc. develops, manufactures and markets POC. POCs are used by patients who suffer from chronic respiratory conditions and need long-term oxygen therapy. POCs concentrate the air around the patient, filter out the nitrogen and other unwanted substances and deliver oxygen. The company provides oxygen concentrator solutions for portable and stationary use. Inogen's flagship product, One G4 is a single-solution POC.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.